Amlodipine Besylate and Benazepril Hydrochloride
- Product NDC
- 70518-3303
- 11-digit product format
- 705183303
- Labeler code
- 70518
- Product ID
- 70518-3303_d3c0e88a-a8eb-9f05-e053-2a95a90a8f82
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Amlodipine Besylate and Benazepril Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA078466
- Marketing category
- ANDA
- Marketing start
- 2021-12-22
- Marketing end
- 0000-00-00
- Substance
- AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
- Active strength
- 5 mg/1; mg/1
- Pharmacologic classes
- Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS],Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-3303-0 | 70518330300 | 28 CAPSULE in 1 BLISTER PACK (70518-3303-0) | 28 capsule | 2021-12-22 | 0000-00-00 | No | No | Current |